Research Site

Marburg, Hesse 35043

1 studies enrolling now · 6 studies all time

What they study most

Asthma, COPD, Chronic Obstructive Pulmonary Disease, Hepatobiliary Cancers, Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis, Supranuclear Palsy, Progressive

Studies at this site

• Observational Study Protocol: LIVER-R — Recruiting now
• Observational Study of Obstructive Lung Disease (NOVELTY) — Completed
• Study of BIIB092 in Participants With Progressive Supranuclear Palsy — Stopped early
• Long-Term Extension Study in Participants With Multiple Sclerosis Who Have Completed Study 205MS301 (NCT01064401) to Evaluate the Safety and Efficacy of BIIB019 — Stopped early
• Efficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple Sclerosis — Completed
• Treatment Interruption of Natalizumab — Completed